Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Brown

Showing results (231-240 of 259) with videos related to

Pageof 26
Sort By:
Retina (Philadelphia, Pa.)|March 7, 2024
SUPRACHOROIDAL SPACE INJECTION TECHNIQUE: Expert Panel GuidanceCharles C Wykoff, Robert L Avery, Mark R Barakat, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|May 15, 2025
Pegcetacoplan for Geographic Atrophy Over 30 Months: Data From OAKS, DERBY, and the GALE Long-Term Extension StudyRoger A Goldberg, David S Boyer, Frank G Holz, et al.
Ophthalmology|October 23, 2012
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degenerationJeffrey S Heier, David M Brown, Victor Chong, et al.
Ophthalmology. Retina|June 28, 2024
Biosimilar Candidate CT-P42 in Diabetic Macular Edema: 24-Week Results from a Randomized, Active-Controlled, Phase III StudySebastian Wolf, Paulo-Eduardo Stanga, Milan Veselovsky, et al.
JAMA Ophthalmology|October 30, 2015
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical PracticeJeffrey S Heier, Neil M Bressler, Robert L Avery, et al.
Ophthalmology and Therapy|August 29, 2025
Long-Term Efficacy and Safety of CT-P42 in Patients with Diabetic Macular Edema: 52-Week Results from a Phase 3 Randomized Clinical TrialDavid M Brown, Sebastian Wolf, Milan Veselovsky, et al.
Ophthalmology|November 25, 2006
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema, David J Browning, Adam R Glassman, et al.
Journal of Vitreoretinal Diseases|November 3, 2025
Patient Reported Experiences and Comfort Associated with Intravitreal Injection Technique: A Cross-Sectional Survey ApproachElahhe R Afkhamnejad, Zainub A Abdullah, Orion M Q Nguyen, et al.
Gigascience|January 13, 2018
Analysis of the Aedes albopictus C6/36 genome provides insight into cell line utility for viral propagationJason R Miller, Sergey Koren, Kari A Dilley, et al.
Therapeutic Advances in Ophthalmology|July 14, 2025
Plain language summary of publication of the 48-week results from the PHOTON study: intravitreal aflibercept 8 mg for diabetic macular edemaDavid M Brown, David S Boyer, Diana V Do, et al.
Pageof 26

Showing results (231-240 of 259) with videos related to

Sort By:
Pageof 26
Retina (Philadelphia, Pa.)|March 7, 2024
SUPRACHOROIDAL SPACE INJECTION TECHNIQUE: Expert Panel GuidanceCharles C Wykoff, Robert L Avery, Mark R Barakat, et al.
Ophthalmic Surgery, Lasers & Imaging Retina|May 15, 2025
Pegcetacoplan for Geographic Atrophy Over 30 Months: Data From OAKS, DERBY, and the GALE Long-Term Extension StudyRoger A Goldberg, David S Boyer, Frank G Holz, et al.
Ophthalmology|October 23, 2012
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degenerationJeffrey S Heier, David M Brown, Victor Chong, et al.
Ophthalmology. Retina|June 28, 2024
Biosimilar Candidate CT-P42 in Diabetic Macular Edema: 24-Week Results from a Randomized, Active-Controlled, Phase III StudySebastian Wolf, Paulo-Eduardo Stanga, Milan Veselovsky, et al.
JAMA Ophthalmology|October 30, 2015
Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical PracticeJeffrey S Heier, Neil M Bressler, Robert L Avery, et al.
Ophthalmology and Therapy|August 29, 2025
Long-Term Efficacy and Safety of CT-P42 in Patients with Diabetic Macular Edema: 52-Week Results from a Phase 3 Randomized Clinical TrialDavid M Brown, Sebastian Wolf, Milan Veselovsky, et al.
Ophthalmology|November 25, 2006
Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema, David J Browning, Adam R Glassman, et al.
Journal of Vitreoretinal Diseases|November 3, 2025
Patient Reported Experiences and Comfort Associated with Intravitreal Injection Technique: A Cross-Sectional Survey ApproachElahhe R Afkhamnejad, Zainub A Abdullah, Orion M Q Nguyen, et al.
Gigascience|January 13, 2018
Analysis of the Aedes albopictus C6/36 genome provides insight into cell line utility for viral propagationJason R Miller, Sergey Koren, Kari A Dilley, et al.
Therapeutic Advances in Ophthalmology|July 14, 2025
Plain language summary of publication of the 48-week results from the PHOTON study: intravitreal aflibercept 8 mg for diabetic macular edemaDavid M Brown, David S Boyer, Diana V Do, et al.
Pageof 26